about
A genetic association study of serum acute-phase C-reactive protein levels in rheumatoid arthritis: implications for clinical interpretationThe PTPN22 locus and rheumatoid arthritis: no evidence for an effect on risk independent of Arg620Trp.Only one independent genetic association with rheumatoid arthritis within the KIAA1109-TENR-IL2-IL21 locus in Caucasian sample sets: confirmation of association of rs6822844 with rheumatoid arthritis at a genome-wide level of significanceThe SLC2A9 nonsynonymous Arg265His variant and gout: evidence for a population-specific effect on severityClinical and ultrasound examination of the leeds enthesitis index in psoriatic arthritis and rheumatoid arthritis.APLAR rheumatoid arthritis treatment recommendations.Could the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) be a valid measure of disease activity in patients with psoriatic arthritis?The renal urate transporter SLC17A1 locus: confirmation of association with gout.PTPN22 R620W minor allele is a genetic risk factor for giant cell arteritis.Association of variation in Fcgamma receptor 3B gene copy number with rheumatoid arthritis in Caucasian samples.The ITGAV rs3738919 variant and susceptibility to rheumatoid arthritis in four Caucasian sample sets.Prevalence of HLA-B27 in the New Zealand population: effect of age and ethnicity.Inpatient management of gout in a New Zealand hospital: a retrospective audit.Replication of association of the apolipoprotein A1-C3-A4 gene cluster with the risk of gout.No evidence for association of Chr 9p21 variant rs1333049 with gout in New Zealand case-control sample sets.Role of the urate transporter SLC2A9 gene in susceptibility to gout in New Zealand Māori, Pacific Island, and Caucasian case-control sample sets.Frequency of CYP2C9 polymorphisms in Polynesian people and potential relevance to management of gout with benzbromarone.Comparison of rates of referral and diagnosis of axial spondyloarthritis before and after an ankylosing spondylitis public awareness campaign.Hyperuricaemia elevates circulating CCL2 levels and primes monocyte trafficking in subjects with inter-critical gout.Association of the PTPN22 locus with rheumatoid arthritis in a New Zealand Caucasian cohort.The genetic associations of acute anterior uveitis and their overlap with the genetics of ankylosing spondylitis.The deleted in colorectal carcinoma (DCC) gene 201 R --> G polymorphism: no evidence for genetic association with autoimmune disease.Patient age, ethnicity and waiting times determine the likelihood of non-attendance at a first specialist rheumatology assessment.Genomic DNA pooling for whole-genome association scans in complex disease: empirical demonstration of efficacy in rheumatoid arthritis.A human leukocyte antigen locus haplotype confers risk for allopurinol-related adverse effects in Caucasian patients with goutReplication of association of the interleukin 23 receptor rs1343151 variant with rheumatoid arthritis in Caucasian sample setsA strong role for the ABCG2 gene in susceptibility to gout in New Zealand Pacific Island and Caucasian, but not Māori, case and control sample setsEvidence for an influence of chemokine ligand 3-like 1 (CCL3L1) gene copy number on susceptibility to rheumatoid arthritisDisease Activity Score 28-ESR bears a similar relationship to treatment decisions across different rheumatologists, but misclassification is too frequent to replace physician judgementPrenatal transfer of anticardiolipin antibodies associated with fatal neonatal aortic thrombosisDoes a joint count calibration exercise make a difference? Implications for clinical trials and trainingDifferences in MSU-induced superoxide responses by neutrophils from gout subjects compared to healthy controls and a role for environmental inflammatory cytokines and hyperuricemia in neutrophil function and survivalRaynaud's phenomenon in medical laboratory workers who work with solventsRules of engagement: turning recommendations into results in the diagnosis and management of goutTreat-to-target in rheumatoid arthritis: Evaluating the patient perspective using the Patient Opinion Real-Time Anonymous Liaison system: The RA T2T PORTAL study2018 update of the APLAR recommendations for treatment of rheumatoid arthritisUnderstanding fatigue-related disability in rheumatoid arthritis and ankylosing spondylitis: The importance of daily correlates
P50
Q28475543-59ECBB01-05C4-413C-B035-EFB202F81709Q33727899-7D661684-EB71-483A-AB86-B29628C8CE13Q34027620-9206687F-AD5E-40AF-9A3B-0FF629AB1504Q35557878-03C00A99-380F-41D1-BFAA-54800C5A2FEBQ35687813-F89303CA-503F-4388-818E-9F95DDD3594FQ35762912-1B568CBA-CA12-4963-BE97-262083F3D5C2Q35799566-C7897CBC-FDB3-4FD8-A01F-C08C3F97E384Q36245877-46665A60-D144-496F-8DE8-B7425E9BBC48Q36819307-159ED99A-67EB-4573-AB3C-079F3A1E6DACQ36896439-436870B8-3339-45AD-8A4F-19963EBCDC47Q37453924-CFBBBCE7-DCF1-4884-A47C-B8BD8449BA35Q37690183-908EB630-7123-4158-B121-4BE3D0A3386AQ38420885-6AB9EC92-B19F-4CCD-8344-1C1E215B3B49Q39838705-10238DB8-9AF9-463C-88A2-A191DC091A51Q42477346-A287D7BD-7FE4-424F-A0CA-9DC973673BA7Q43251977-239885F4-D327-43C0-BF2B-7AABE6288298Q43687107-D3CE2876-7867-47BA-8AEC-79FD84C25593Q45235699-564A4087-EE74-4327-B608-678396CA7E77Q46449377-977FE19C-1903-4681-A328-CADDA38811EDQ46573581-AE94C8B1-AEEF-4899-90D7-C60E99C16BDAQ52145849-FD439904-D6BD-4389-953C-59274178E8D6Q52956128-752F74A6-975A-45AB-8E17-19E98E363DA1Q54325661-2117DCDF-6729-4341-B4F6-4D3C03761093Q54330502-7592A4F3-1648-4F98-9B45-72808EC12215Q57154656-89B722C8-C855-48DD-89A1-6DAB0A82322EQ57154811-0A74368D-247F-4471-974A-1CFBFE68278BQ57154884-B69DB9B8-8938-4920-8B2F-13F442B0481CQ57154947-352CF39C-47B2-4F4A-8C66-E50D4712FC82Q80824590-9B6C8D03-3F0E-469E-91F2-B951DFD55F4CQ81507427-4BA5E711-EE1E-4DD5-859C-0142E5A96957Q83788463-B0E23014-90A6-40FC-8ECB-40B66CFA91D2Q84068852-67277C60-0C69-4AFC-AF41-3BE5D4CAD164Q84371234-D8B080DB-8FAE-47C5-A8CA-04C4EB57E141Q87211061-0FEA9AFB-4091-486B-BCD9-C6F766AD8997Q91826366-AE4B4358-CA66-4408-AC68-B4610F417BE7Q91952724-071D31A3-273D-4A76-A890-9077C23FD9D1Q93256593-40845ADF-55CA-43D3-AC9D-1CB1D2472681
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Andrew A Harrison
@ast
Andrew A Harrison
@en
Andrew A Harrison
@es
Andrew A Harrison
@nl
type
label
Andrew A Harrison
@ast
Andrew A Harrison
@en
Andrew A Harrison
@es
Andrew A Harrison
@nl
altLabel
Harrison AA
@en
prefLabel
Andrew A Harrison
@ast
Andrew A Harrison
@en
Andrew A Harrison
@es
Andrew A Harrison
@nl
P106
P21
P31
P496
0000-0003-4372-3252